BioCentury | Nov 17, 2003
Finance

Ebb & Flow

...at MPM Capital. Prior to that, he was president and CEO of age-related disease company Centagenetix...
BioCentury | Nov 14, 2003
Financial News

Platika joins Pittsburgh VC

...advisor at MPM Capital. Before MPM, he was president and CEO of age-related disease company Centagenetix...
BioCentury | Feb 17, 2003
Company News

Centagenetix, Elixir Pharmaceuticals deal

...Elixir Pharmaceuticals name and will focus on identifying drug targets to address diseases of aging. Centagenetix Inc....
BioCentury | Feb 17, 2003
Company News

Elixir Pharmaceuticals management update

...Mass. Business: Genomics Transition: Bard Geesaman to VP of medical from VP of informatics at Centagenetix Inc....
BioCentury | Feb 12, 2003
Financial News

Elixir raises $17 million

...Bioscience Partners. The company is the result of Wednesday's completed merger between Elixir Pharmaceuticals and Centagenetix...
BioCentury | Jan 13, 2003
Company News

Centagenetix merging with Elixir

...transaction. The deal combines Elixir's technology on the biology and molecular genetics of aging and Centagenetix's...
BioCentury | Jan 13, 2003
Company News

Centagenetix, Elixir Pharmaceuticals deal

...transaction. The deal combines Elixir’s technology on the biology and molecular genetics of aging and Centagenetix’s...
...longevity. The technologies will be combined to identify drug targets to address diseases of aging. Centagenetix Inc....
BioCentury | Dec 9, 2002
Company News

Centagenetix, Boston University, Boston Medical Center deal

...have rights to use resulting discoveries for academic purposes and will be eligible for royalties. Centagenetix Inc....
BioCentury | May 20, 2002
Company News

Centagenetix management update

Centagenetix Inc. , Cambridge, Mass. Business: Genomics Hired: Doros Platika as CEO, formerly chairman and CEO of Curis Inc. WIR Staff...
BioCentury | May 13, 2002
Company News

Centagenetix names Platika CEO

...Mass.) hired Doros Platika as CEO. Platika was formerly chairman and CEO of Curis (CRIS). Centagenetix...
Items per page:
1 - 10 of 12
BioCentury | Nov 17, 2003
Finance

Ebb & Flow

...at MPM Capital. Prior to that, he was president and CEO of age-related disease company Centagenetix...
BioCentury | Nov 14, 2003
Financial News

Platika joins Pittsburgh VC

...advisor at MPM Capital. Before MPM, he was president and CEO of age-related disease company Centagenetix...
BioCentury | Feb 17, 2003
Company News

Centagenetix, Elixir Pharmaceuticals deal

...Elixir Pharmaceuticals name and will focus on identifying drug targets to address diseases of aging. Centagenetix Inc....
BioCentury | Feb 17, 2003
Company News

Elixir Pharmaceuticals management update

...Mass. Business: Genomics Transition: Bard Geesaman to VP of medical from VP of informatics at Centagenetix Inc....
BioCentury | Feb 12, 2003
Financial News

Elixir raises $17 million

...Bioscience Partners. The company is the result of Wednesday's completed merger between Elixir Pharmaceuticals and Centagenetix...
BioCentury | Jan 13, 2003
Company News

Centagenetix merging with Elixir

...transaction. The deal combines Elixir's technology on the biology and molecular genetics of aging and Centagenetix's...
BioCentury | Jan 13, 2003
Company News

Centagenetix, Elixir Pharmaceuticals deal

...transaction. The deal combines Elixir’s technology on the biology and molecular genetics of aging and Centagenetix’s...
...longevity. The technologies will be combined to identify drug targets to address diseases of aging. Centagenetix Inc....
BioCentury | Dec 9, 2002
Company News

Centagenetix, Boston University, Boston Medical Center deal

...have rights to use resulting discoveries for academic purposes and will be eligible for royalties. Centagenetix Inc....
BioCentury | May 20, 2002
Company News

Centagenetix management update

Centagenetix Inc. , Cambridge, Mass. Business: Genomics Hired: Doros Platika as CEO, formerly chairman and CEO of Curis Inc. WIR Staff...
BioCentury | May 13, 2002
Company News

Centagenetix names Platika CEO

...Mass.) hired Doros Platika as CEO. Platika was formerly chairman and CEO of Curis (CRIS). Centagenetix...
Items per page:
1 - 10 of 12